









Markets
/
Stocks
/
nasdaq-cai
/

Caris Life Sciences Inc

CAI

27.940USD

+0.080+0.29%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

7.88BMarket Cap

LossP/E TTM



Caris Life Sciences Inc

27.940

+0.080+0.29%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Caris Life Sciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

--62.42M

--7.29M

---31.34M

Net income from continuing operations

--24.32M

---71.79M

---102.58M

Operating gains losses

--4.87M

--6.41M

--7.04M

Other non-cash items

--3.41M

--27.94M

--3.85M

Change in working capital

--14.09M

---1.44M

--13.32M

-Change in receivables

--24.19M

--29.13M

--7.91M

-Change in inventory

---8.52M

---4.68M

--2.06M

-Change in prepaid expenses

---2.54M

---4.74M

--2.47M

-Change in other current assets

---660.00K

--298.00K

--36.00K

Cash from non-recurring investing activities

Cash from operating activities

--62.42M

--7.29M

---31.34M

Investing cash flow

Net cash from continuing investing activities

--7.09M

--1.39M

--2.69M

Capital expenditures

--7.09M

--1.39M

--2.69M

Net cash flow from disposal of fixed assets

--7.09M

--1.39M

--2.69M

Net cash flow from investment products

--0.00

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

---7.09M

---1.39M

---2.69M

Financing cash flow

Cash flow from continuous financing activities

---21.10M

--681.40M

--1.28M

Net cash flow from debt Issuance/repayment

---23.00K

--23.84M

---22.00K

Net cash flow from common stock issuance/repurchase

--0.00

--528.46M

---22.00K

Net cash flow from preferred stock issuance/repurchase

--0.00

--121.24M

----

Proceeds from stock option exercised by employees

--1.15M

--1.19M

--1.43M

Proceeds from issuance of warrants

--0.00

--10.27M

----

Net cash flow from other financing activities

---22.23M

---3.60M

---105.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

---21.10M

--681.40M

--1.28M

Net cash flow

Beginning cash balance

--722.69M

--35.29M

--68.03M

Current period cash flow changes

--34.30M

--687.40M

---32.74M

Effect of exchange rate changes

--62.00K

--93.00K

--4.00K

Ending cash balance

--756.98M

--722.69M

--35.29M

Free cash flow

--55.33M

--5.90M

---34.03M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

